Medtronic Agreement (Details) - Medtronic Agreement - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|
| Medtronic agreement | ||||
| Reimbursable research and development expense | $ 4,000,000 | $ 1,900,000 | $ 7,400,000 | $ 3,100,000 |
| Proceeds from issuance of Series D-2 Preferred Stock | 40,000,000 | |||
| Revenue recognized to date | $ 0 | 0 | ||
| Minimum | ||||
| Medtronic agreement | ||||
| Expected to receive product price | 500 | |||
| Maximum | ||||
| Medtronic agreement | ||||
| Expected to receive product price | 1,600 | |||
| Accounts Payable and Accrued Expenses | ||||
| Medtronic agreement | ||||
| Reimbursable research and development expense | $ 6,200,000 | |||